How is Polatuzumab Vedotin-Piiq dosed?
The usual dose for adults is 1.8 mg/kg of body weight given as an intravenous infusion over 90 minutes. The dosage may vary depending on the individual's response to the treatment and any potential side effects. It is essential to follow the dosage instructions provided by your doctor, as improper dosing can lead to ineffective treatment or increased risk of side effects. Always consult your healthcare provider for personalized dosing information.
What is the dosage form of Polatuzumab Vedotin-Piiq?
The dosage form of Polatuzumab Vedotin-Piiq for the intravenous route is Powder for Solution.
How is Polatuzumab Vedotin-Piiq administered?
Polatuzumab Vedotin-Piiq is administered by a nurse or other trained health professional in a medical facility. It is given through a needle placed into one of the veins. The needle must be kept in place for at least 90 minutes every 21 days for a total of 6 cycles.
What are common precautions when taking Polatuzumab Vedotin-Piiq?
Common precautions when taking Polatuzumab Vedotin-Piiq intravenous route include:
- Allergies: Inform your doctor if you have ever had any unusual or allergic reactions to this medicine or any other medicines. Additionally, mention any other types of allergies, such as to foods, dyes, preservatives, or animals.
- Pediatric: Safety and efficacy have not been established for children younger than 18 years of age. Consult with your doctor before administering this medication to a child.
- Geriatric: Safety and efficacy have not been established in patients older than 65 years. Consult your doctor before using this medication in older adults.
- Breastfeeding: There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
- Drug Interactions: Inform your doctor about all the medicines you are currently taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Some drug interactions may cause severe adverse effects.
- Direct Supervision: This medicine should be given only by or under the direct supervision of a healthcare professional.
- Injection Site Reactions: Injection site reactions, such as pain, swelling, or redness, may occur during the administration of the medication. Inform your healthcare professional if you experience any injection site reactions.